Lung Cancer
Commentary
For NSCLC, neoadjuvant, adjuvant, or both?
I think it’s a great place for shared decision-making because if a patient hears about that and decides they’re not interested, I’ll be fine with...
News
RFS failed as endpoint in adjuvant immunotherapy trials
“Our meta-analysis failed to find a significantly strong association between RFS and OS in RCTs of adjuvant immunotherapy,” the authors concluded...
News
Short bursts of activity may cut cancer risk
Examples of such activity are vigorous housework, carrying heavy shopping bags around the grocery store, bursts of power walking, and playing high...
News
No benefit to adding limited radiation in advanced cancer
Median overall survival was not significantly better with radiotherapy, compared with the control group, nor was the objective response rate.
News
Diabetes may short circuit pembrolizumab benefits in NSCLC
"There is an urgent need to validate our findings and explore whether outcomes in these patients can be improved by better glycemic control."
Article
Cancer Data Trends 2023
Article
Lung Cancer Screening in Veterans
Recap
Treating Veterans With Small-Cell Lung Cancer
Veterans are at increased risk for small-cell lung cancer because of smoking and exposure history. In this ReCAP, Dr Shadia Jalal discusses...
Conference Coverage
Multiprong strategy makes clinical trials less White
Only a small percentage of eligible patients participate in clinical trials in the first place, and very few come from racial and ethnic minority...
Conference Coverage
CBSM phone app eases anxiety, depression in cancer patients
Few patients with cancer have access to psycho-oncologic support.
